Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Advances in systemic sclerosis and related fibrotic and vascular conditions

Genetic factors in systemic sclerosis

Maureen D Mayes* and Maria Trojanowska

Arthritis Research & Therapy 2007, 9(Suppl 2):S5 doi:10.1186/ar2189

Accesses  

  • Last 30 days: 58 accesses
  • Last year: 452 accesses
  • All time: 3042 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions

Omer Raheem, Anna A Kulidjian, Christina Wu, Young B Jeong, Tomonori Yamaguchi, Kristen M Smith, Daniel Goff, Heather Leu, Sheldon R Morris, Nicholas A Cacalano, Koichi Masuda, Catriona HM Jamieson, Christopher J Kane, Christina AM Jamieson Journal of Translational Medicine 2011, 9:185 (28 October 2011)

Research article   Open Access

A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation

Lorenzo Beretta, Marta Cossu, Maurizio Marchini, Francesca Cappiello, Andrea Artoni, Giovanna Motta, Raffaella Scorza Arthritis Research & Therapy 2008, 10:R103 (1 September 2008)

Preface   Free

Systemic sclerosis and related connective tissue diseases: present and future

Lewis J Rubin, Carol M Black, Christopher P Denton, James R Seibold Arthritis Research & Therapy 2007, 9(Suppl 2):S1 (15 August 2007)